Top compounds associated with response to TXNL4A

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	BRD-K92856060	CTRPv2	pan-cancer	AAC	0.11	0.003
mRNA	Methotrexate	GDSC1000	pan-cancer	AAC	0.091	0.003
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.11	0.003
mRNA	WZ3105	GDSC1000	pan-cancer	AAC	0.091	0.003
mRNA	Parthenolide	CTRPv2	pan-cancer	AAC	0.12	0.004
mRNA	GNF-2	GDSC1000	pan-cancer	AAC	-0.17	0.004
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.1	0.004
mRNA	BRD-K51490254	CTRPv2	pan-cancer	AAC	0.11	0.004
mRNA	embelin	GDSC1000	pan-cancer	AAC	-0.11	0.004
mRNA	WH-4-023	GDSC1000	pan-cancer	AAC	-0.16	0.004

Download CSV